UNIVEST FINANCIAL Corp lifted its position in PACCAR Inc (NASDAQ:PCAR) by 1.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,672 shares of the company’s stock after acquiring an additional 617 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in PACCAR were worth $3,273,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Parallel Advisors LLC grew its position in shares of PACCAR by 32.9% in the 1st quarter. Parallel Advisors LLC now owns 1,717 shares of the company’s stock worth $117,000 after acquiring an additional 425 shares in the last quarter. New York State Common Retirement Fund grew its position in shares of PACCAR by 9.2% in the 1st quarter. New York State Common Retirement Fund now owns 963,868 shares of the company’s stock worth $65,678,000 after acquiring an additional 80,968 shares in the last quarter. Kennedy Capital Management Inc. grew its position in shares of PACCAR by 3.7% in the 1st quarter. Kennedy Capital Management Inc. now owns 71,757 shares of the company’s stock worth $4,890,000 after acquiring an additional 2,584 shares in the last quarter. Meiji Yasuda Life Insurance Co grew its position in shares of PACCAR by 11.8% in the 1st quarter. Meiji Yasuda Life Insurance Co now owns 7,551 shares of the company’s stock worth $515,000 after acquiring an additional 798 shares in the last quarter. Finally, Lido Advisors LLC grew its position in shares of PACCAR by 48.0% in the 1st quarter. Lido Advisors LLC now owns 18,369 shares of the company’s stock worth $1,251,000 after acquiring an additional 5,958 shares in the last quarter. Institutional investors own 63.34% of the company’s stock.
NASDAQ:PCAR traded up $0.21 during midday trading on Wednesday, reaching $71.18. 26,206 shares of the company traded hands, compared to its average volume of 1,678,605. PACCAR Inc has a twelve month low of $53.43 and a twelve month high of $73.00. The stock has a market capitalization of $24.83 billion, a price-to-earnings ratio of 11.40, a price-to-earnings-growth ratio of 1.26 and a beta of 1.25. The company has a quick ratio of 1.40, a current ratio of 1.64 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $70.84.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Wednesday, August 14th will be given a dividend of $0.32 per share. The ex-dividend date is Tuesday, August 13th. This represents a $1.28 dividend on an annualized basis and a yield of 1.80%. PACCAR’s dividend payout ratio (DPR) is presently 20.51%.
In other PACCAR news, VP David J. Danforth sold 4,315 shares of the business’s stock in a transaction on Friday, May 3rd. The stock was sold at an average price of $70.69, for a total transaction of $305,027.35. Following the completion of the transaction, the vice president now owns 7,286 shares in the company, valued at approximately $515,047.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP David J. Danforth sold 848 shares of the business’s stock in a transaction on Friday, July 26th. The stock was sold at an average price of $71.66, for a total value of $60,767.68. Following the transaction, the vice president now owns 4,958 shares of the company’s stock, valued at approximately $355,290.28. The disclosure for this sale can be found here. Insiders have sold a total of 23,149 shares of company stock valued at $1,614,832 in the last quarter. 2.32% of the stock is currently owned by insiders.
Several research analysts have recently commented on PCAR shares. JPMorgan Chase & Co. reiterated a “buy” rating on shares of SAGE Therapeutics in a research report on Wednesday, July 24th. BidaskClub upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Thursday, July 4th. Morgan Stanley decreased their target price on Lionsgate from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. Credit Suisse Group boosted their price objective on Canadian National Railway from $101.00 to $104.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, BMO Capital Markets boosted their price objective on PACCAR to $70.00 and gave the company a “market perform” rating in a research report on Friday, May 17th. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $68.89.
PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, and internationally. The company operates in three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks that are used for the over-the-road and off-highway hauling of commercial and consumer goods.
Want to see what other hedge funds are holding PCAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PACCAR Inc (NASDAQ:PCAR).
Receive News & Ratings for PACCAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACCAR and related companies with MarketBeat.com's FREE daily email newsletter.